Search Results

Filter
  • 1-10 of  493,836 results for ""COVID-19 Vaccines""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Examination of diet quality and alcohol on serum IgG levels after first and second COVID-19 vaccines.

  • Authors : Cesur F; Department of Nutrition, Institute of Health Science, Ege University, İzmir, Turkey.

Subjects: Immunoglobulin G*/Immunoglobulin G*/Immunoglobulin G*/blood ; Alcohol Drinking*/Alcohol Drinking*/Alcohol Drinking*/immunology ; COVID-19*/COVID-19*/COVID-19*/prevention & control

  • Source: Journal of evaluation in clinical practice [J Eval Clin Pract] 2024 Dec; Vol. 30 (8), pp. 1769-1781. Date of Electronic Publication: 2024 Sep 23.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9609066 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Effectiveness of Original Monovalent and Bivalent COVID-19 Vaccines Against COVID-19-Associated Hospitalization and Severe In-Hospital Outcomes Among Adults in the United States, September 2022-August 2023.

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/immunology

  • Source: Influenza and other respiratory viruses [Influenza Other Respir Viruses] 2024 Nov; Vol. 18 (11), pp. e70027.Publisher: Wiley Country of Publication: England NLM ID: 101304007 Publication Model: Print Cited Medium: Internet ISSN: 1750-2659 (Electronic)

Record details

×
Academic Journal

Serious adverse events following immunization with COVID-19 vaccines in Lebanon: a retrospective analysis of the National Pharmacovigilance Database.

  • Authors : Karam R; Department of Chemistry and Biochemistry, Faculty of Science, Section 1, Lebanese University, Beirut, Lebanon.; Quality Assurance of Pharmaceutical Products Department, Lebanese Ministry of Public Health, Beirut, Lebanon.

Subjects: Pharmacovigilance* ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage

  • Source: BMC public health [BMC Public Health] 2024 Oct 21; Vol. 24 (1), pp. 2905. Date of Electronic Publication: 2024 Oct 21.Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2458

Record details

×
Academic Journal

Association of new onset seizure and COVID-19 vaccines and long-term follow-up: A systematic review and meta-analysis.

  • Authors : Rafati A; School of Medicine, Iran University of Medical Sciences, Tehran, Iran.; Jameie M

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects ; Seizures*/Seizures*/Seizures*/epidemiology ; Seizures*/Seizures*/Seizures*/etiology

  • Source: Epilepsia [Epilepsia] 2024 Oct; Vol. 65 (10), pp. 3010-3027. Date of Electronic Publication: 2024 Aug 27.Publisher: Blackwell Science Country of Publication: United States NLM ID: 2983306R Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Substantial reduction in the clinical and economic burden of disease following variant-adapted mRNA COVID-19 vaccines in immunocompromised patients in France.

  • Authors : Lee A; Quadrant Health Economics Inc, Cambridge, Ontario, Canada.; Davido B

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/economics ; COVID-19*/COVID-19*/COVID-19*/immunology SARS-CoV-2 variants

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2423474. Date of Electronic Publication: 2024 Nov 14.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Antibody dynamics for heterologous boosters with aerosolized Ad5-nCoV following inactivated COVID-19 vaccines.

  • Authors : Chen C; State Key Laboratory of Respiratory Disease, National Clinical Research Centre for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.; Tang T

Subjects: Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/blood ; Antibodies, Neutralizing*/Antibodies, Neutralizing*/Antibodies, Neutralizing*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2423466. Date of Electronic Publication: 2024 Nov 13.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Humoral and cellular immune response to AZD1222 /Covishield and BV152/Covaxin COVID-19 vaccines among adults in India.

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; Antibodies, Viral*/Antibodies, Viral*/Antibodies, Viral*/blood

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2410579. Date of Electronic Publication: 2024 Oct 21.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Genomic insights into mRNA COVID-19 vaccines efficacy: Linking genetic polymorphisms to waning immunity.

  • Authors : Hsieh MJ; Department of Family Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.; Tsai PH

Subjects: COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; COVID-19*/COVID-19*/COVID-19*/prevention & control COVID-19 breakthrough infections

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2399382. Date of Electronic Publication: 2024 Sep 10.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis.

  • Authors : Hua T; Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing, China.; Fan R

Subjects: Neoplasms*/Neoplasms*/Neoplasms*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2357424. Date of Electronic Publication: 2024 May 24.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Top 100 cited research on COVID-19 vaccines: A bibliometric analysis and evidence mapping.

  • Authors : Yu L; Child Rehabilitation Department, Gansu Rehabilitation Center Hospital, Lanzhou, Gansu, China.; Xu C

Subjects: Bibliometrics* ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/administration & dosage ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology

  • Source: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2370605. Date of Electronic Publication: 2024 Jul 08.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  493,836 results for ""COVID-19 Vaccines""